NMTR(Delisted)
9 MetersยทNASDAQ
--
--(--)
NMTR Profile
9 Meters Biopharma, Inc.
A clinical-stage company pioneering novel treatments for rare or debilitating digestive diseases
4509 Creedmoor Road, Suite 600, Raleigh, NC 27612
--
9 Meters Biopharma, Inc., is a clinical-stage company pioneering new treatments for people suffering from rare digestive diseases, gastrointestinal diseases with unmet needs, and debilitating diseases caused by biological factors in the gut. The company's pipeline includes vurolenatide, a patented Phase 3 long-acting GLP-1 agonist for SBS, and a strong pipeline of early stage drug candidates for undisclosed rare diseases or unmet needs.
